Pharmasset, Inc. (VRUS) Posts Q2 Loss of 60c, Wider than Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Goldman says this FX trade is the best hedge for the AI drawdown
Tweet
Share
E-mailGet Alerts VRUS Hot Sheet
Price: $0.00 --0%
Financial Fact:
Net loss per share: basic and diluted: -0.6
Today's EPS Names:
KEEL, SENEA, XFOR, More
Financial Fact:
Net loss per share: basic and diluted: -0.6
Today's EPS Names:
KEEL, SENEA, XFOR, More
Join SI Premium – FREE
Pharmasset, Inc. (NASDAQ: VRUS) reported Q2 loss of ($0.60), $0.02 worse than the analyst estimate of ($0.58).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ANI Pharma (ANIP) Tops Q3 EPS by 52c ; Offers Guidance
- Insight Enterprises (NSIT) Tops Q3 EPS by 73c ; Offers Guidance
- Lipocine (LPCN) Tops Q3 EPS by 24c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
